These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 19994586

  • 1. [Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study].
    Yamada J.
    Nippon Ganka Gakkai Zasshi; 2009 Nov; 113(11):1082-7. PubMed ID: 19994586
    [Abstract] [Full Text] [Related]

  • 2. Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study.
    Yamada J, Hamuro J, Hatanaka H, Hamabata K, Kinoshita S.
    J Allergy Clin Immunol; 2007 May; 119(5):1119-26. PubMed ID: 17379290
    [Abstract] [Full Text] [Related]

  • 3. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
    Hazama S, Watanabe S, Ohashi M, Yagi M, Suzuki M, Matsuda K, Yamamoto T, Suga Y, Suga T, Nakazawa S, Oka M.
    Anticancer Res; 2009 Jul; 29(7):2611-7. PubMed ID: 19596936
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Anticancer immunotherapy with perorally effective lentinan].
    Hamuro J.
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1209-15. PubMed ID: 16121931
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patients with hepatocellular carcinoma.
    Isoda N, Eguchi Y, Nukaya H, Hosho K, Suga Y, Suga T, Nakazawa S, Sugano K.
    Hepatogastroenterology; 2009 Aug; 56(90):437-41. PubMed ID: 19579616
    [Abstract] [Full Text] [Related]

  • 8. Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study.
    Kirmaz C, Bayrak P, Yilmaz O, Yuksel H.
    Eur Cytokine Netw; 2005 Jun; 16(2):128-34. PubMed ID: 15941684
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer.
    Shimizu K, Watanabe S, Watanabe S, Matsuda K, Suga T, Nakazawa S, Shiratori K.
    Hepatogastroenterology; 2009 Jun; 56(89):240-4. PubMed ID: 19453066
    [Abstract] [Full Text] [Related]

  • 10. A double-blind randomized placebo-controlled trial with short-term beta-glucuronidase therapy in children with chronic rhinoconjunctivitis and/or asthma due to dust mite allergy.
    Galli E, Bassi MS, Mora E, Martelli M, Gianni S, Auricchio G, Arabito E, Rossi P.
    J Investig Allergol Clin Immunol; 2006 Jun; 16(6):345-50. PubMed ID: 17153881
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W.
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
    Gordon M, Bihari B, Goosby E, Gorter R, Greco M, Guralnik M, Mimura T, Rudinicki V, Wong R, Kaneko Y.
    J Med; 1998 May; 29(5-6):305-30. PubMed ID: 10503166
    [Abstract] [Full Text] [Related]

  • 14. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC, Hoyte EG, McIntire JJ, Umetsu DT.
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [Abstract] [Full Text] [Related]

  • 16. Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis.
    Powell RJ, Frew AJ, Corrigan CJ, Durham SR.
    Allergy; 2007 Nov; 62(11):1335-8. PubMed ID: 17714551
    [Abstract] [Full Text] [Related]

  • 17. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S, Heinrich C, Scheynius A.
    Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
    [Abstract] [Full Text] [Related]

  • 18. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
    Horiguchi S, Tanaka Y, Uchida T, Chazono H, Ookawa T, Sakurai D, Okamoto Y.
    Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160
    [Abstract] [Full Text] [Related]

  • 19. Tolerability and clinical outcome of coseasonal treatment with Escherichia coli strain Nissle 1917 in grass pollen-allergic subjects.
    Dölle S, Berg J, Rasche C, Worm M.
    Int Arch Allergy Immunol; 2014 Mar; 163(1):29-35. PubMed ID: 24247760
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G, Larsen TH, Rak S, Horak F, Pastorello E, Valenta R, Purohit A, Arvidsson M, Kavina A, Schroeder JW, Mothes N, Spitzauer S, Montagut A, Galvain S, Melac M, André C, Poulsen LK, Malling HJ.
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.